Nearly two dozen lawmakers introduced identical bills in the House and Senate Wednesday that take a kitchen sink approach to tackling the rising cost of medicines, from allowing Medicare to negotiate prices to removing tax breaks that drug makers receive for advertising expenses.
Dubbed the Improving Access to Affordable Prescription Drugs Act, the legislation comes amid mounting controversy over prescription drug prices, a hot-button issue that has put the pharmaceutical industry on the defensive as a growing number of polls show Americans want the government to take action.
About the Author Reprints
Appreciate efforts of Senators Franken and Sanders to lower drug prices, but why don’t they require those drugs and devices to also be labeled truthfully and not omit material risk and safety information when those products are often used off-label?